Neurology · 2000 · 71 citations · 8 references
MedicineNeurologyNeuroscienceDementiaNeurodegenerationNeuropathologyCreutzfeldt-jakob DiseaseDementia With Lewy BodiesLewy Body DementiaNeurodegenerative DiseasesNeurodegenerative DisordersNeuropathology Of DementiaCerebrospinal Fluid 14-3-3 ProteinCreutzfeldt-jakob Disease PathologyDiagnosis Of Creutzfeldt-jakob DiseaseLewy Body Dementia BiomarkersLewy Body Dementia DiagnosisMicroscopic Neuropathologic ExaminationNeuropathologic Lesion DescriptionSpongiform Degeneration
Discriminating Creutzfeldt-Jakob disease (CJD) from dementia with Lewy bodies (DLB) may be clinically difficult to achieve. The authors describe 10 patients with DLB initially referred to the French Network of Human Spongiform Encephalopathies as having suspected CJD. In a series of 465 autopsied cases, DLB ranked second among degenerative alternative diagnoses to CJD. The authors analyzed the factors that contributed to misleading the diagnosis, and suggest that the detection of 14-3-3 protein in CSF may be useful to distinguish CJD from DLB.
8
Diffuse Lewy body disease: clinical features in 15 cases.
E. Jane Byrne, Graham Lennox, James Lowe et al. · Journal of Neurology Neurosurgery & Psychiatry · 1989 · 313 citations · Full text
EEG findings in dementia with Lewy bodies and Alzheimer's disease
Ruth Briel, Ian G. McKeith, WAYNE BARKER et al. · Journal of Neurology Neurosurgery & Psychiatry · 1999 · 164 citations · Full text
Medicine, Neurology, Neuroscience +16